MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
21.34
-0.02
-0.07%
After Hours: 21.52 +0.18 +0.84% 19:30 12/05 EST
OPEN
21.37
PREV CLOSE
21.36
HIGH
21.38
LOW
21.33
VOLUME
1.64M
TURNOVER
--
52 WEEK HIGH
23.57
52 WEEK LOW
6.38
MARKET CAP
2.08B
P/E (TTM)
-3880.0000
1D
5D
1M
3M
1Y
5Y
1D
Alkermes To Acquire Avadel Pharmaceuticals In Shareholder Scheme, Sends Proposal To Equity And Employee Share Purchase Plan Holders
Benzinga · 18h ago
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
Barchart · 3d ago
AVADEL PHARMACEUTICALS PLC - SCHEME MEETING AND EGM SCHEDULED FOR JANUARY 12, 2026
Reuters · 4d ago
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
Barchart · 5d ago
Weekly Report: what happened at AVDL last week (1124-1128)?
Weekly Report · 5d ago
Hold Rating on Avadel Pharmaceuticals Amid Acquisition Offer and Market Uncertainties
TipRanks · 11/26 21:15
Jefferies expects Avadel-Alkermes deal to close
TipRanks · 11/26 21:05
Weekly Report: what happened at AVDL last week (1117-1121)?
Weekly Report · 11/24 09:50
More
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Webull offers Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ: AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.